Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Erythropoietin (EPO) Market with Focus on Asia (2016-2020) - Key Vendors are Amgen, Roche Holding & Teva Pharmaceutical Industries - Research and Markets

Research and Markets
Posted on: 11 Nov 16

Research and Markets has announced the addition of the "Global Erythropoietin (EPO) Market with Focus on Asia- Industry Analysis & Outlook (2016-2020)" report to their offering.

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle and brain's response to neuronal injury.

People suffering from End Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology.

On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs.

The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies.

Companies Mentioned:

  • Amgen Inc.
  • Johnson & Johnson
  • Roche Holding AG
  • Teva Pharmaceutical Industries Limited

Key Topics Covered:

1. Overview

2. Global EPO Market

3. Regional Markets

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/8bvm4p/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20161111005264/en/

Business Wire
www.businesswire.com

Last updated on: 11/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.